The UConn Health Dermatology Clinical Trials Unit is looking for adults diagnosed with bullous pemphigoid (BP) to participate
in a research study. The Liberty-BP Study is a study of an investigational medication for those
diagnosed with BP.
You may qualify for the study if you:
• Are 18-90 years old
• Have been diagnosed with bullous pemphigoid
• Haven’t been treated for cancer in the past five years (excluding certain types of cervical and skin cancer)
• Meet additional study criteria
Principal Investigator: Jun Lu, MD
IRB #: W20225-1
To learn more about the study and to see if you may qualify, please contact Ektor Rafti, MD, at erafti@uchc.edu or Sueheidi Santiago, MD, at susantiago@uchc.edu.
For more information, contact: Sueheidi Santiago, M.D., at susantiago@uchc.edu